Gao Xiao-Ning, Yu Li
Department of Hematology, General Hospital of PLA, 28 Fuxing Road, Beijing 100853, China.
Biochem Biophys Res Commun. 2008 Jun 6;370(3):399-403. doi: 10.1016/j.bbrc.2008.03.058. Epub 2008 Mar 20.
The KIR3DL1 gene is a member of killer immunoglobulin-like receptors family, which exhibits a variegated expression pattern in NK cells and subsets of CD4(+) and CD8(+) T cells. The E2F family of transcription factors plays a crucial role in the regulation of gene expression. The present study reports a naturally occurring point mutation (TTTGGCGC-->TTCGGCGC) within a putative E2F binding site in the KIR3DL1 promoter in K562 cells. Interestingly, this mutation introduces a new methylation site. This study shows for the first time that E2F1 binds to the KIR3DL1 promoter in vivo. This point mutation and concomitantly altered methylation pattern within the E2F1 binding site abolishes their binding and reduces the promoter activity, while elevated expression of E2F1 correlates with increased promoter activity. Therefore, E2F1 contributes to the transcriptional activation of the KIR3DL1 gene.
KIR3DL1基因是杀伤细胞免疫球蛋白样受体家族的成员,在自然杀伤细胞以及CD4(+)和CD8(+) T细胞亚群中呈现多样化的表达模式。E2F转录因子家族在基因表达调控中起关键作用。本研究报道了K562细胞中KIR3DL1启动子假定的E2F结合位点内存在一个天然发生的点突变(TTTGGCGC→TTCGGCGC)。有趣的是,该突变引入了一个新的甲基化位点。本研究首次表明E2F1在体内与KIR3DL1启动子结合。E2F1结合位点内的这一点突变以及随之改变的甲基化模式消除了它们的结合并降低了启动子活性,而E2F1表达升高与启动子活性增加相关。因此,E2F1有助于KIR3DL1基因的转录激活。